These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 21468572)
1. Sulforaphane blocks hypoxia-mediated resistance to TRAIL-induced tumor cell death. Jeong JK; Moon MH; Seo JS; Seol JW; Lee YJ; Park SY Mol Med Rep; 2011; 4(2):325-30. PubMed ID: 21468572 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia inducing factor-1alpha regulates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in tumor cells exposed to hypoxia. Jeong JK; Moon MH; Seo JS; Seol JW; Park SY; Lee YJ Biochem Biophys Res Commun; 2010 Aug; 399(3):379-83. PubMed ID: 20659427 [TBL] [Abstract][Full Text] [Related]
3. TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells. Jin CY; Molagoda IMN; Karunarathne WAHM; Kang SH; Park C; Kim GY; Choi YH Toxicol Appl Pharmacol; 2018 Aug; 352():132-141. PubMed ID: 29792947 [TBL] [Abstract][Full Text] [Related]
4. Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells. Matsui TA; Sowa Y; Yoshida T; Murata H; Horinaka M; Wakada M; Nakanishi R; Sakabe T; Kubo T; Sakai T Carcinogenesis; 2006 Sep; 27(9):1768-77. PubMed ID: 16571651 [TBL] [Abstract][Full Text] [Related]
5. Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. Jeon YK; Yoo DR; Jang YH; Jang SY; Nam MJ Biochim Biophys Acta; 2011 Oct; 1814(10):1340-8. PubMed ID: 21640852 [TBL] [Abstract][Full Text] [Related]
6. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression. Harashima N; Takenaga K; Akimoto M; Harada M Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028 [TBL] [Abstract][Full Text] [Related]
7. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells. Yao H; Wang H; Zhang Z; Jiang BH; Luo J; Shi X Int J Cancer; 2008 Sep; 123(6):1255-61. PubMed ID: 18561315 [TBL] [Abstract][Full Text] [Related]
8. Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice. Bergantin E; Quarta C; Nanni C; Fanti S; Pession A; Cantelli-Forti G; Tonelli R; Hrelia P Cancer Biol Ther; 2014 Sep; 15(9):1219-25. PubMed ID: 24971463 [TBL] [Abstract][Full Text] [Related]
9. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells. Jin CY; Moon DO; Lee JD; Heo MS; Choi YH; Lee CM; Park YM; Kim GY Carcinogenesis; 2007 May; 28(5):1058-66. PubMed ID: 17183064 [TBL] [Abstract][Full Text] [Related]
10. Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environment. Mayes PA; Campbell L; Ricci MS; Plastaras JP; Dicker DT; El-Deiry WS Cancer Biol Ther; 2005 Oct; 4(10):1068-74. PubMed ID: 16294025 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism. Pei GT; Wu CW; Lin WW Biochem Biophys Res Commun; 2010 Jan; 391(2):1274-9. PubMed ID: 20018172 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced down-modulation of PKCepsilon promotes trail-mediated apoptosis of tumor cells. Gobbi G; Masselli E; Micheloni C; Nouvenne A; Russo D; Santi P; Matteucci A; Cocco L; Vitale M; Mirandola P Int J Oncol; 2010 Sep; 37(3):719-29. PubMed ID: 20664941 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia. Oh ET; Kim CW; Kim SJ; Lee JS; Hong SS; Park HJ Sci Rep; 2016 Jun; 6():27382. PubMed ID: 27263528 [TBL] [Abstract][Full Text] [Related]
14. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Kim H; Kim EH; Eom YW; Kim WH; Kwon TK; Lee SJ; Choi KS Cancer Res; 2006 Feb; 66(3):1740-50. PubMed ID: 16452234 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis. Nardinocchi L; Puca R; Sacchi A; D'Orazi G Mol Cancer; 2009 Jan; 8():1. PubMed ID: 19128456 [TBL] [Abstract][Full Text] [Related]
16. Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin. Lee YJ; Lee JH; Moon JH; Park SY Int J Mol Sci; 2014 Jul; 15(7):11941-56. PubMed ID: 25000265 [TBL] [Abstract][Full Text] [Related]
17. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872 [TBL] [Abstract][Full Text] [Related]
18. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway. Gong T; Cui L; Wang H; Wang H; Han N J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced apoptosis of mouse spermatocytes is mediated by HIF-1α through a death receptor pathway and a mitochondrial pathway. Yin J; Ni B; Liao WG; Gao YQ J Cell Physiol; 2018 Feb; 233(2):1146-1155. PubMed ID: 28444885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]